Conference Day 1, Thursday 13 November 2025 (4pm to 8pm)

Audience: Physicians from Internal Medicine, primary health care, Rhinology, pulmonology and allergists in the private section as well as those from locally, regionally and internationally

Location: Le Royal Meridien, Lusail, Doha, Qatar

Overall Objectives:

  • To have an overview of severe asthma management
  • To discuss the current state of science in food allergies
  • To be aware of the available biologic for severe asthma and CRSwNP
  • To have an overview of the use of allergen immunotherapy to treat allergic diseases
Time Topic Speaker
3 pm to 3.30 pm Registration ALL

Session 1: Allergen Immunotherapy
Moderators: Dr Pascal Demoly (France), Dr Fatima Ashkanani (Qatar)

4.30 pm to 4.50 pm Allergen Immunotherapy from Clinical Trials to Real-Life Studies
Objective: To identify the types and indications of AIT
Prof. Moises Calderon (UK)
4.50 pm to 5.10 pm Food Immunotherapy Current Answers and Unresolved Questions
Objective: To discuss the indications and limitations of AIT for food allergy
Dr Davide Caimmi (France)
5.10 pm to 5.20 pm Questions and discussion  
5.20 pm to 5.30 pm Prayer & Break  

Session 2: Biologics in Severe Asthma 
Moderators: Dr. Loie Goronfolah (KSA), Dr. Mona Al-Ahmad (Kuwait), Prof. Philip Rouadi (Kuwait/Lebanon)

5.30 pm to 5.50 pm How to Choose Biological Agents in Severe Asthma
Objective: To discuss the factors that help in the selection of biological treatment
Dr Juan Carlos Cardet (USA)
5.50 pm to 6.20 pm Remission, Response and Non-response in Asthma
Objective: To have an overview of remission in asthma and how to assess the response of severe asthma to treatment
Dr Hassan Mobayed (Qatar)
6.35 pm to 6.55 pm What is New in CRSwNP?
Objective: To discuss updates in CRSwNP management
Dr Tayseer Ibrahim (Qatar)
6.55 pm to 7.15 pm Severe Asthma Diagnosis and Management Update in 2025
Objective: To have an overview of updates in severe asthma diagnosis and management
Dr Connie Katelaris (Australia)
7.15 pm to 7.35 pm Real-world Data on Severe Asthma Patients from the International Severe Asthma Registry (ISAR)
Objective: To discuss severe asthma patients' data from the ISAR
Dr. Désirée Larenas- Linnemann (Mexico)
7.35 pm to 7.45 pm​ Questions and discussion  
End of Day 1​​​​​​